FGF23 is associated with inflammation through IL-6 (interleukin 6), IL-10 (interleukin 10), and CRP (C-reactive protein) and with symptoms of metabolic syndrome: insulin resistance, visceral obesity, and dyslipidemia [107,109,110]. The gene discussed is CRP; the disease is Insulin resistance.